These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24577334)

  • 1. Comments on recent advances and recommendations for the assessment of autoantibodies to cellular antigens referred as antinuclear antibodies.
    Mahler M; Dervieux T
    Ann Rheum Dis; 2014 Jul; 73(7):e36. PubMed ID: 24577334
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antinuclear antibodies: added value of solid phase assay?
    Bossuyt X; Fieuws S
    Ann Rheum Dis; 2014 Mar; 73(3):e10. PubMed ID: 24257025
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: 'Detection of antinuclear antibodies: added-value of solid phase assay?' by Bossuyt and Fieuws.
    Agmon-Levin N; Damoiseaux J; Shoenfeld Y
    Ann Rheum Dis; 2014 Mar; 73(3):e11. PubMed ID: 24318859
    [No Abstract]   [Full Text] [Related]  

  • 4. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
    Agmon-Levin N; Damoiseaux J; Kallenberg C; Sack U; Witte T; Herold M; Bossuyt X; Musset L; Cervera R; Plaza-Lopez A; Dias C; Sousa MJ; Radice A; Eriksson C; Hultgren O; Viander M; Khamashta M; Regenass S; Andrade LE; Wiik A; Tincani A; Rönnelid J; Bloch DB; Fritzler MJ; Chan EK; Garcia-De La Torre I; Konstantinov KN; Lahita R; Wilson M; Vainio O; Fabien N; Sinico RA; Meroni P; Shoenfeld Y
    Ann Rheum Dis; 2014 Jan; 73(1):17-23. PubMed ID: 24126457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases.
    Tan EM
    Adv Dent Res; 1996 Apr; 10(1):44-6. PubMed ID: 8934923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibody titer and antibodies to extractable nuclear antigens.
    Bossuyt X; Hendrickx A; Frans J
    Arthritis Rheum; 2005 Dec; 53(6):987-8. PubMed ID: 16342092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 10. Standards of care: the value and importance of standardization.
    Smolen JS; Steiner G; Tan EM
    Arthritis Rheum; 1997 Mar; 40(3):410-2. PubMed ID: 9082925
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice.
    Bizzaro N; Wiik A
    Clin Exp Rheumatol; 2004; 22(3):349-55. PubMed ID: 15144133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we at a stage to predict autoimmune rheumatic diseases?
    Bizzaro N; Tozzoli R; Shoenfeld Y
    Arthritis Rheum; 2007 Jun; 56(6):1736-44. PubMed ID: 17530702
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
    Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
    Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate laboratory testing in rheumatic diseases.
    Metzger AL; Morris RI
    Lippincotts Prim Care Pract; 1998; 2(1):52-65. PubMed ID: 9451199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.
    Solomon DH; Kavanaugh AJ; Schur PH;
    Arthritis Rheum; 2002 Aug; 47(4):434-44. PubMed ID: 12209492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies].
    Marmont A; Damasio E
    G Mal Infett Parassit; 1968 Jan; 20(1):124-32. PubMed ID: 4880275
    [No Abstract]   [Full Text] [Related]  

  • 20. Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
    Rahman A; Stollar BD
    Lupus; 2008 Mar; 17(3):232-5. PubMed ID: 18372367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.